Munafa Stock Market Course + Intraday & FNO calls 
Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for USA stock HALO Halozyme Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 109.62 and Closed at: 108.31, which is -1.43% of previous session's close. It moved within a range of 107.68 and 109.87
The session was a Bearish session with an average volume of 1856100, which is -40.06% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 106.9 and resistance for tomorrow is 109.09
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 107.37, 106.43 resistance for tomorrow's hourly charts is 109.56, 110.81
10 Day SMA for Halozyme Therapeutics (HALO) is 111.66 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 110.14 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 103.46 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 88.29 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 78.7 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 110.14 and 200 DMA is at 78.7, while 50 DMA and 100 DMA are at 103.46 and 88.29 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 110.14 and 20 EMA is at 109.61
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 108.31 | 110.14 | 109.61 |
| 02 Fri Oct | 109.86 | 110.23 | 109.75 |
| 01 Thu Oct | 106.94 | 110.28 | 109.74 |
| 30 Wed Sep | 110.40 | 110.41 | 110.03 |
| 29 Tue Sep | 111.56 | 110.28 | 109.99 |
| 28 Mon Sep | 112.89 | 110.02 | 109.82 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 103.46 and 50 EMA is at 102.86
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 108.31 | 103.46 | 102.86 |
| 02 Fri Oct | 109.86 | 102.94 | 102.64 |
| 01 Thu Oct | 106.94 | 102.38 | 102.35 |
| 30 Wed Sep | 110.40 | 101.85 | 102.16 |
| 29 Tue Sep | 111.56 | 101.2 | 101.82 |
| 28 Mon Sep | 112.89 | 100.54 | 101.42 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 88.29 and 100 EMA is at 93.21
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 108.31 | 88.29 | 93.21 |
| 02 Fri Oct | 109.86 | 87.91 | 92.91 |
| 01 Thu Oct | 106.94 | 87.52 | 92.57 |
| 30 Wed Sep | 110.40 | 87.12 | 92.28 |
| 29 Tue Sep | 111.56 | 86.65 | 91.91 |
| 28 Mon Sep | 112.89 | 86.19 | 91.51 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 78.7 and 200 EMA is at 83.3
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 108.31 | 78.7 | 83.3 |
| 02 Fri Oct | 109.86 | 78.49 | 83.05 |
| 01 Thu Oct | 106.94 | 78.26 | 82.78 |
| 30 Wed Sep | 110.40 | 78.04 | 82.54 |
| 29 Tue Sep | 111.56 | 77.8 | 82.26 |
| 28 Mon Sep | 112.89 | 77.55 | 81.96 |
Halozyme Therapeutics has performed better than Takeda Pharmaceutical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Laboratory Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Inspire Medical has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Inspire Medical, about 13.86% more returns!
Haemonetics Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 1.79% more returns!
Halozyme Therapeutics has performed better than Glaukos Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Elanco Animal in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Brookdale Senior in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Neuronetics Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Quidel Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Karyopharm Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Inovio Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Cue Biopharma in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Cooper Companies in short term. Holding Halozyme Therapeutics could be a better choice for now!
Biolife Solutions has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 9.13% more returns!
Halozyme Therapeutics has performed better than Ascendis Pharma in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Aquestive Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Aptevo Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Akebia Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 111.78 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
